Article Details
Retrieved on: 2022-05-27 19:57:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche (OTCQX:RHHBY), the parent company of Genentech, recently won European Commission approval of Polivy (polatuzumab vedotin) for diffuse large ...
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here